International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer Focus on HER2-low and Ultralow Categories /
The concept of "HER2-negative" breast cancer is evolving, with the recognition of HER2-low and HER2-ultralow subsets. These subsets are clinically relevant regarding treatment with the antibody-drug conjugate trastuzumab deruxtecan (T-DXd), which has shown survival benefit in patients with...
Elmentve itt :
Hasonló tételek
-
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021 a systematic analysis for the Global Burden of Disease Study 2021 /
Szerző: Kollaborációs szervezet: GBD 2021 Risk Factors Collaborators, et al.
Megjelent: (2024) -
Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
Szerző: Cserni Gábor, et al.
Megjelent: (2021) -
The church and her responsibility
Szerző: Florovsky Georges
Megjelent: (1947) -
The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration
Szerző: Sly Peter D., et al.
Megjelent: (2018) -
Lichens of the Arboretum at Tiszakürt and her surroundings
Szerző: Gallé László
Megjelent: (1967)